Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.
about
A "SMART" design for building individualized treatment sequencesExperimental design and primary data analysis methods for comparing adaptive interventions.Dynamic Treatment RegimesModeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching timesInference about the expected performance of a data-driven dynamic treatment regime.Optimization of multi-stage dynamic treatment regimes utilizing accumulated dataExpression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.Inference for non-regular parameters in optimal dynamic treatment regimesInference for the median residual life function in sequential multiple assignment randomized trials.Q-LEARNING WITH CENSORED DATA.Sample size calculations for evaluating treatment policies in multi-stage designs.Introduction to dynamic treatment strategies and sequential multiple assignment randomization.Pattern-mixture-type Estimation and Testing of Neuroblastoma Treatment RegimesSMART designs in cancer research: Past, present, and future.Sample size formulae for two-stage randomized trials with survival outcomesCumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical TrialsResults of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.Innovative Clinical Trial Designs: Toward a 21st-Century Health Care SystemPrognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative studyDeveloping adaptive treatment strategies in substance abuse researchEstimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study.Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.Innovative designs of point-of-care comparative effectiveness trials.Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study.Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Design Issues in Randomized Clinical Trials of Maintenance Therapies.Adaptive Interventions in Child and Adolescent Mental HealthIssues in using progression-free survival when evaluating oncology productsPersonalizing medicine: a review of adaptive treatment strategies.A global logrank test for adaptive treatment strategies based on observational studies.Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.Comparing treatment policies with assistance from the structural nested mean model.Improve efficiency and reduce bias of Cox regression models for two-stage randomization designs using auxiliary covariates.Use of personalized Dynamic Treatment Regimes (DTRs) and Sequential Multiple Assignment Randomized Trials (SMARTs) in mental health studies.Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.On Sparse representation for Optimal Individualized Treatment Selection with Penalized Outcome Weighted Learning.Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-Oncology Research.Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies.Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.Penalized Q-Learning for Dynamic Treatment Regimens
P2860
Q24619631-9CA1D2D9-0695-4B5A-81CB-1F0CA47D7927Q30571530-03BE9BEF-5665-442B-8B9B-2138088D41CCQ30597725-B25FC11D-EAB3-4056-B9F1-36DF1289343CQ30655744-031FC829-72D7-4EB6-A748-E154BF7B6D6DQ30830842-F8ADDC21-2CC1-4029-ACD3-0139878DD527Q30975658-0772D15E-EE49-4DD7-9656-20F039CBBDD9Q33832087-713D9424-FAD6-4149-A375-86942A0A2357Q33937413-04B29652-D07A-472B-9F20-F563578F515FQ34127385-32513BA8-A6C4-455A-9882-32A9018452D1Q34323965-35754B4A-0969-4778-9B15-E04B08158F79Q34393655-7646C3A2-BA33-47B8-86A9-70E8A9B020F8Q34437881-D8AD967D-0596-454F-AE1E-709DAB55426AQ35149324-C9ED7331-6D0B-4809-AA0D-0DACB6DF2BE4Q35607162-B77A69B8-6967-4AC1-B672-308BDF314D9EQ35662139-6D6A96CC-D0BF-4E11-8BE9-909C65B15B1BQ35741333-E42E64FD-2890-4D5F-8650-CA524DBBC727Q35750976-6F3B75A9-2976-47E6-919E-6089A9B99FAAQ35797280-928579B4-0987-4655-A0E0-E20E9151E7E6Q35849663-6546FC56-3416-4504-903F-B6AF03CD637DQ35896960-20F2668C-86A1-4E2C-820B-8160CFE5439DQ36142974-81E88D56-F504-4FB3-AC03-8FAFE81175E9Q36206859-58AF71F5-9F15-4558-A41D-63291B55869EQ36264914-7D3F9387-877A-4BF6-8152-A8EE85EFDAC6Q36330858-703E65A6-7ED3-4BE2-B417-B65280A1A2A1Q36534104-FD288439-E17F-45DA-8A0B-B4A071567B5BQ36848078-41434C43-1E6C-4DFC-A7AB-93B9E4D6FCB5Q37059108-FC3DB2E7-5A11-46E1-8168-E015DF185058Q37231532-BDADFD8D-779B-4227-86BD-48FFCE18AB5EQ38202081-76DF9732-E6D6-4E81-833E-D8F436D265FCQ38381538-3680F8A0-F443-41DC-9EFD-16A674571778Q38730575-6AF9677C-EB4C-471D-93CB-B687E495FDBAQ38957369-FA04B0A1-5984-4D22-BAE9-2000E412EE4BQ38969245-0C589589-A96D-4ECF-ADF6-296466A8ACBBQ39044502-313E623B-DA13-45E2-8D82-33CE5F1AA941Q39372860-28CB56C6-C4CF-4F36-97EA-655506371C73Q39569323-E8D19FB4-A757-44AE-9214-4E162F13D3CDQ40073118-DF88326C-7815-46EE-9346-32B8E90D749EQ40240806-B5CFC441-05BC-44C1-95AF-91395428DE2FQ40543401-89B32E81-16A4-47C7-805A-83F2386EF484Q40642766-9DCCED4A-2F68-40A3-A361-CED97CB1A64A
P2860
Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Estimation of survival distrib ...... on designs in clinical trials.
@ast
Estimation of survival distrib ...... on designs in clinical trials.
@en
Estimation of survival distrib ...... on designs in clinical trials.
@nl
type
label
Estimation of survival distrib ...... on designs in clinical trials.
@ast
Estimation of survival distrib ...... on designs in clinical trials.
@en
Estimation of survival distrib ...... on designs in clinical trials.
@nl
prefLabel
Estimation of survival distrib ...... on designs in clinical trials.
@ast
Estimation of survival distrib ...... on designs in clinical trials.
@en
Estimation of survival distrib ...... on designs in clinical trials.
@nl
P2093
P2860
P1433
P1476
Estimation of survival distrib ...... on designs in clinical trials.
@en
P2093
Anastasios A Tsiatis
Jared K Lunceford
Marie Davidian
P2860
P356
10.1111/J.0006-341X.2002.00048.X
P407
P577
2002-03-01T00:00:00Z